The biopharmaceutical industry’s Covid-influenced evolution
![Harris 2021 12 Burford Capital Group #2 0734 B&W Sm](/media/vbtfz4zm/harris-2021_12_burford-capital_group-2_0734_bw_sm.jpg?rxy=0.232,0.3119891008174387&width=520&height=390&v=1d9f343e280f1c0)
The disruption of 2020 presented one of the biggest and most important challenges to the biotech and pharmaceutical industries. Learn how the pandemic has led to a reevaluation of investment in R&D, an increased interest in parallel therapies and an evolution in how companies manage associated legal risks.
2020 was a transformative year for all businesses, but pharmaceutical companies in particular were challenged to innovate, collaborate and generate results directly connected to solving a public health crisis.
From the outset, it was clear that the industr…